Affluent Medical Sas Stock Profit Margin
AFME Stock | 1.38 0.04 2.82% |
Affluent Medical SAS fundamentals help investors to digest information that contributes to Affluent Medical's financial success or failures. It also enables traders to predict the movement of Affluent Stock. The fundamental analysis module provides a way to measure Affluent Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Affluent Medical stock.
Affluent |
Affluent Medical SAS Company Profit Margin Analysis
Affluent Medical's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition |
Based on the latest financial disclosure, Affluent Medical SAS has a Profit Margin of 0.0%. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The profit margin for all France stocks is 100.0% lower than that of the firm.
Did you try this?
Run Alpha Finder Now
Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk |
All Next | Launch Module |
Affluent Fundamentals
Return On Equity | -0.36 | |||
Return On Asset | -0.12 | |||
Operating Margin | (8.42) % | |||
Current Valuation | 50.42 M | |||
Shares Outstanding | 20.6 M | |||
Shares Owned By Insiders | 3.35 % | |||
Shares Owned By Institutions | 65.00 % | |||
Price To Book | 0.99 X | |||
Price To Sales | 22.19 X | |||
Gross Profit | (1.29 M) | |||
EBITDA | (9.87 M) | |||
Net Income | (14.82 M) | |||
Cash And Equivalents | 11.41 M | |||
Total Debt | 17 M | |||
Book Value Per Share | 1.95 X | |||
Cash Flow From Operations | (12.36 M) | |||
Earnings Per Share | (0.77) X | |||
Target Price | 3.8 | |||
Number Of Employees | 49 | |||
Market Capitalization | 30.06 M | |||
Total Asset | 70.03 M | |||
Z Score | 0.6 | |||
Net Asset | 70.03 M |
About Affluent Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Affluent Medical SAS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Affluent Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Affluent Medical SAS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Affluent Stock
Affluent Medical financial ratios help investors to determine whether Affluent Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Affluent with respect to the benefits of owning Affluent Medical security.